Featured
Read our handpicked blogs, curated for you.
|
The Growing Risk of AI Vendor Lock-InEnterprise AI adoption is accelerating at an extraordinary pace. Organizations are…
|
The Silent Crisis in Enterprise AIEnterprises are rapidly deploying AI copilots, autonomous agents, retrieval systems,…
|
The Rising Risk in Modern Digital WorkplacesEmployees share files across Teams, SharePoint, email, and external…
Recent releases
|
Tier 2 and Tier 3 Doctors: Pharma’s Untapped Growth Engine
For years, Indian pharma marketing has been obsessed with metros. Strategies are designed for doctors in Mumbai, Delhi, Bangalore, and Hyderabad, as if prescribing behavior outside these hubs hardly…
|
Cutting Pharma Content Approval Cycles with Modular Ops
Every pharma marketer in India knows the feeling. A new campaign is planned, deadlines are set, and the brand team is ready to move. Then the medical-legal-regulatory (MLR) process begins. Weeks go…
|
The UCPMP 2024 Rulebook- What Pharma CMOs Need to Change in Marketing Ops
For years, Indian pharma operated in a grey zone where marketing practices were loosely monitored. That time is over. The UCPMP 2024 Rulebook (Uniform Code of Pharmaceutical Marketing Practices) has…
|
Why Indian Pharma Keeps Failing at Digital Transformation
Digital Transformation is the buzzword that never dies in Indian pharma boardrooms. Every annual strategy deck promises it. Every leadership summit talks about it. Yet when you look closely, most…
